Diagnostics firms to boost R&D spending on home testing by 2035v

More than half have already commercialised home or self-testing products.

Investment in home and self-testing is rising, with nearly half (46%) of diagnostics companies expecting to allocate 6–15% of their research and development (R&D) budgets to these products by 2035.

On a global scale, 32% anticipate dedicating 16–30% of R&D spending to these products within the next decade, according to a Simon-Kucher report.

More than half of diagnostics companies have already commercialised home or self-testing products, whilst 34% are actively developing them.

Companies are adjusting business models to reflect changing consumer behaviour, comply with new regulations, and address structural challenges in the sector, the report said.

Only 9% remain in early-stage exploration, whilst 6% have no plans for home testing.